Skip to main content
Premium Trial:

Request an Annual Quote

Precision Bio, Bayer CropScience Extend Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Precision BioSciences and Bayer CropScience have extended an existing plant bioengineering partnership to include development of new enzymes for use in crop development programs.

Under the new agreement, the companies will work together to develop Precision Bio’s Direct Nuclease Editor-engineered enzymes for use in Bayer CropScience’s crop development projects.

The original agreement, announced last year, gave Bayer non-exclusive access to Precision Bio’s DNE technology for use in modifying plant genomes to develop novel traits in plants and provided Bayer with multiple enzymes for its crop platforms.

The DNE technology is based on the production of custom DNA-cleaving enzymes that the company calls meganucleases, which enable crop researchers to delete, insert, or otherwise modify genes at user-defined endogenous sites within plant genomes.

Precision Bio said today that during the first phase of the partnership, the DNE technology enabled Bayer to target the insertion and removal of DNA at pre-determined locations in a plant genome.

The company said that by making it easier to introduce favorable traits into plant species, its DNE technology can help companies streamline development and reduce the time it takes to get a new product to the market.

Financial and other terms of the agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.